Diagnostic and therapeutic considerations for primary penal synovial sarcoma with specific MDM2 gene amplification: A case report

doi:10.5410/wjcu.v14.i1.104791

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

(111)

(117)

(0)

(13)

(1705)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Urology

ISSN

2219-2816

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Urol. Mar 18, 2025; 14(1): 104791
Published online Mar 18, 2025. doi: 10.5410/wjcu.v14.i1.104791

Full Size Figure Download Figure

Figure 1 The preoperative computed tomography images of the patient. A: The plain scan of computed tomography examination shows a cystic- solid mass shadow with uneven density; B: After enhanced scanning, it shows heterogeneous enhancement; C: The solid part in the venous phase shows a "fast in and slow out" performance.

Citation: Deng CH, Zhou Y, Chen J, He GF, Fu QS, Li JM, Wang G, Hu XD. Diagnostic and therapeutic considerations for primary penal synovial sarcoma with specific MDM2 gene amplification: A case report. World J Clin Urol 2025; 14(1): 104791
URL: https://www.wjgnet.com/2219-2816/full/v14/i1/104791.htm
DOI: https://dx.doi.org/10.5410/wjcu.v14.i1.104791

Deng CH, Zhou Y, Chen J, He GF, Fu QS, Li JM, Wang G, Hu XD. Diagnostic and therapeutic considerations for primary penal synovial sarcoma with specific MDM2 gene amplification: A case report. World J Clin Urol 2025; 14(1): 104791 [DOI: 10.5410/wjcu.v14.i1.104791]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.